Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Imai, Y. Articles by Miyake, M. Search for Related Content PubMed PubMed Citation Articles by Imai, Y. Articles by Miyake, M.

 Previous Article  |  Next Article 

Infection and Immunity, February 2003, p. 985-990, Vol. 71, No. 2
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.2.985-990.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Restricted Expression of Shiga Toxin Binding Sites on Mucosal Epithelium of Mouse Distal Colon

Yasuyuki Imai,^1,2* Takashi Fukui,¹ Kohta Kurohane,¹ Daisei Miyamoto,³ Yasuo Suzuki,^2,3 Tomoyuki Ishikawa,¹ Yousuke Ono,¹ and Masaki Miyake¹

Department of Microbiology,¹ Department of Biochemistry,³ COE Program in the 21st Century, University of Shizuoka School of Pharmaceutical Sciences, Shizuoka 422-8526, Japan²

Received 30 August 2002/ Returned for modification 4 October 2002/ Accepted 13 November 2002

Top Abstract Introduction Materials and Methods Results Discussion References

 
Shiga toxins (Stx) are some of the major virulence factors of enterohemorrhagic Escherichia coli strains such as serotype O157:H7. To explore how Stx might initially gain access to the bloodstream from sites of infection, frozen sections of mouse colon were immunohistochemically examined for binding sites for recombinant binding subunits (Stx1B). Binding sites were selectively expressed on the epithelium in the distal half of the mouse colon, whereas the proximal half did not exhibit any binding sites. In agreement with this observation, we also demonstrated the distal-part-restricted distribution of glycolipids that bind to Stx1B in the mouse colon. For comparison, the binding sites of several control lectins were also examined. Selective binding to the distal part of the colon was not seen with any other control lectins, including Griffonia simplicifolia lectin-I isolectin B4 (GS-I-B4), which shares -galactose specificity with Stx1B. Partial overlapping of the specificities of Stx1B and GS-I-B4 was seen by assay with globotriose-conjugated multivalent ligands. The results indicate that Stx1B is stricter in the recognition of carbohydrate determinants than GS-I-B4 when examined with biological ligands.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Infection by enterohemorrhagic Escherichia coli (EHEC) strains, such as serotype O157:H7, can result in life-threatening complications, including hemolytic-uremic syndrome (HUS) and central nervous system involvement (19). Shiga toxins (Stx), also called "verotoxins," are exotoxins and virulence factors of EHEC. The Stx consist of a toxin component (A subunit) that inhibits protein synthesis and a cell-binding component (B subunit) (1, 23). B subunits form a pentamer and recognize specific carbohydrate determinants, such as those displayed on the glycolipid globotriaosylceramide (Gb₃; Gal1-4Galß1-4Glcß1-1ceramide) (10, 12).

Glycolipid ligands specific for Stx on endothelial cells have gained much attention, especially in the context of damage to the brain microvasculature. The expression of Gb₃ has been reported to increase on human cerebral endothelial cells upon in vitro treatment with proinflammatory cytokines, such as tumor necrosis factor (2). In mice, upon experimental infection by E. coli O157:H7, an increase in the serum Stx level was followed by apoptosis of brain cells. The presence of Gb₃ as a functional ligand has been demonstrated in mouse brain (9).

Despite these studies of ligands on endothelial cells in target organs, intestinal glycoconjugates have not been clearly demonstrated to be involved in the entry of Stx at the sites of infection. Furthermore, the binding sites for Stx on the intestinal epithelium at or near the sites of EHEC infection have not been well characterized. How Stx initially gains access to the bloodstream upon EHEC infection is still not fully understood, although one possible mechanism has been proposed: i.e., neutrophil transmigration at a site of infection may play a significant role in the entry of Stx (5). In this study, we analyzed the binding sites for Stx in mouse colon by using a sensitive immunohistochemical probe as well as a biochemical approach.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Mice. Specific-pathogen-free female CD-1 (ICR) mice were purchased from SLC Japan (Shizuoka, Japan) and used at 6 to 8 weeks of age. Animal care and experiments were performed in accordance with the ethical guidelines for the animal facilities of the University of Shizuoka.

Reagents. Recombinant binding subunits of Stx1 (Stx1B) were expressed in E. coli JM105(pVT1-B5) cells, and proteins were purified to homogeneity by anion-exchange chromatography and chromatofocusing as described previously (16). The purified Stx1B subunits were labeled with digoxigenin (DIG-Stx1B) as described previously (16). A multivalent carbohydrate ligand (FITC-Gb₃-PLL) consisting of a poly-L-lysine (PLL) backbone conjugated with globotriose and tagged with fluorescein isothiocyanate (FITC) was prepared as described previously (7). Horseradish peroxidase (HRP)-labeled sheep anti-digoxigenin (DIG) Fab fragments (HRP-anti-DIG) were purchased from Roche Diagnostics (Tokyo, Japan). Biotinylated Aleuria aurantia lectin (AAL), biotinylated Lycopersicon esculentum lectin (LEL), biotinylated Ulex europaeus agglutinin I (UEA-I), biotinylated Arachis hypogaea lectin (PNA), biotinylated Griffonia simplicifolia lectin-I isolectin B4 (GS-I-B4), HRP-avidin D, and a 3-amino-9-ethylcarbazole (AEC) substrate kit were purchased from Vector (Burlingame, Calif.), and HRP-rabbit anti-FITC antibody was purchased from Dakopatts (Glostrup, Denmark). Bovine serum albumin (BSA) fraction V and PLL were purchased from Sigma (St. Louis, Mo.), and 2,2'-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) was purchased from Wako Pure Chemicals (Osaka, Japan). Standard glycolipids Gb₃ and galactosylceramide (GalCer; Galß1-1Cer) were prepared from porcine erythrocytes and bovine brain, respectively, as described previously (15).

Immunohistochemistry. Mouse kidneys or colon fragments were embedded in OCT compound (Miles, Elkhart, Ind.) and then frozen in a liquid nitrogen bath. Immunostaining was performed as described previously (6, 20). In brief, cryostat sections (10 µm thick) were picked up on PLL-coated slides and air dried. The sections were fixed in acetone for 30 s at 20°C. Nonspecific binding sites were blocked with 3% BSA in calcium- and magnesium-free Dulbecco's phosphate-buffered saline (PBS) for 10 min at 20°C. The sections were incubated with 50 to 100 µl of either DIG-Stx1B (4 µg/ml), biotinylated AAL (2 µg/ml), biotinylated LEL (4 µg/ml), biotinylated UEA-I (2 µg/ml), biotinylated PNA (2 µg/ml), or biotinylated GS-I-B4 (4 µg/ml) in 3% BSA-PBS for 30 min at 20°C. After each incubation and fixation, the sections were gently washed three times in PBS. The sections were then incubated for 30 min at 20°C with 3% BSA-PBS containing either HRP-anti-DIG (1:300) to reveal the binding sites for Stx1B or HRP-avidin D (5 µg/ml) to reveal those for biotinylated lectins. The binding of the second reagents was detected with the AEC substrate kit.

Extraction of glycolipids and TLC immunostaining. Mice were killed under ether anesthesia and then exsanguinated. The colon and kidneys were removed from each mouse. After removal of feces and gentle rinsing with saline, the proximal (less than 3 cm below the cecum) and distal (more than 5 cm below the cecum) parts of the colons from 10 mice were separately pooled. Each part of the colon was cut into small pieces. Kidneys were crushed with a mortar and pestle. The tissue samples were lyophilized and weighed: proximal colon, 330 mg; distal colon, 383 mg; kidneys, 688 mg (dry weight). Each dry sample was serially extracted with chloroform-methanol (2:1, 1:1, and then 1:2), and the extracts were combined and evaporated. Each sample was dissolved in 4 ml of chloroform-methanol (2:1), and aliquots of 10 µl (colon) or 5 µl (kidney) were separated on a thin-layer chromatography (TLC) plate (Polygram Sil G, Macherey-Nagel, Germany) in chloroform-methanol-water (65:35:8 [vol/vol/vol]) as described previously (16). As references, GalCer (2.5 µg) and Gb₃ (5 µg) were also applied. The plates were subjected to immunostaining with DIG-Stx1B or orcinol-sulfuric acid as described previously (16).

ELISA. A solid-phase binding assay with FITC-Gb₃-PLL was performed as described previously (7). In brief, purified Stx1B or one of the biotin-conjugated lectins was allowed to adsorb to the wells of an enzyme-linked immunosorbent assay (ELISA) plate (catalog no. 9018; Costar, Corning, N.Y.) in PBS for 16 h at 4°C. Nonspecific binding sites were blocked with 1% BSA-PBS for 2 h at 20°C. To detect the binding of carbohydrate ligands, FITC-Gb₃-PLL (100 µl per well) diluted with PBS containing 0.1% Tween 20 (Sigma) and 0.1% BSA (PBS-Tween-BSA) was added. After incubation for 1 h at 20°C, the bound ligands were detected by incubation with 100 µl of HRP-rabbit anti-FITC (2.6 µg/ml) diluted with PBS-Tween-BSA for 1 h at 20°C. Between the incubations, the wells were washed three times with PBS containing 0.1% Tween 20 (PBS-Tween). As a substrate, 1 mM ABTS and 0.034% H₂O₂ in 0.1 M sodium citrate (pH 4.2) were added, and absorbance readings were made with a 405-nm filter. To determine whether the biotinylated lectins were successfully adsorbed to the wells, the wells were incubated with 100 µl of HRP-avidin D (10 µg/ml in PBS-Tween-BSA) for 1 h at 20°C. The binding of HRP-avidin D was detected as described above.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Site-selective expression of binding sites for Stx in mouse colon. Frozen sections of mouse colon were examined for binding sites for recombinant B subunits (DIG-Stx1B) by an immunohistochemical approach. The binding patterns were dramatically different between the proximal and distal parts of the colon. No staining was observed in the proximal part of the colon, indicating the absence of carbohydrate ligands (Fig. 1A and C). In contrast, the epithelium of the distal part of the colon possessed a number of binding sites for DIG-Stx1B, especially in the crypts of Lieberkühn and on the surface of the lumen (Fig. 1B and E). To determine where the transition takes place, frozen sections of mouse colon were examined at 1-cm intervals. Table 1 summarizes the data obtained for four individual mice. The binding of DIG-Stx1B to samples of the colon at positions close to the cecum (less than 4 cm below) was marginal. In contrast, sections from positions far from the cecum (more than 5 cm below) exhibited intense staining of the mucosal epithelium and luminal surface. Such an uneven distribution in the staining pattern was statistically significant (P < 0.005 by the Friedman test).

View larger version (116K): [in this window] [in a new window]

FIG.1. Comparison of the patterns of binding of Stx and various lectins to mouse colon. Acetone-fixed frozen sections of the proximal (<4 cm below the cecum) (A, C, D, G, H, K, and L) or distal (>5 cm below the cecum) (B, E, F, I, J, M, and N) part of the colon were examined separately. The sections were stained with DIG-Stx1B plus HRP-anti-DIG (A, B, C, and E), biotin-GS-I-B4 (D and F), biotin-PNA (G and I), biotin-LEL (H and J), biotin-UEA-I (K and M), or biotin-AAL (L and N). The binding of biotin-conjugated lectins was revealed with HRP-avidin D. The distal part of the colon expressed binding sites for Stx1B (B and E). In contrast, the proximal part of the colon was not stained by Stx1B (A and C). Other lectins did not show a similar site-selective binding pattern. Arrowheads indicate the luminal surface. Arrows indicate the lamina propria (A, C, H, I, and J) or crypts of Lieberkühn (B, E, G, K, L, M, and N). Bars represent 25 µm (A and B [original magnification, x360]) or 100 µm (C to N [original magnification, x90]).

View this table: [in this window] [in a new window]

TABLE 1. Selective expression of binding sites for Stx1B on distal parts of mouse colon

To check specificity of the binding, DIG-Stx1B was applied to the tissue sections in the presence of 50 times excessive amounts of unlabeled Stx1B. Staining of the epithelium of the distal colon was completely inhibited by unlabeled Stx1B (data not shown). Binding of DIG-Stx1B to the renal tubules and collecting ducts from mouse kidneys (6) was also eliminated by unlabeled Stx1B (data not shown). These results establish the specificity of the binding.

Comparison of the binding pattern with those of other lectins. We simultaneously compared the binding patterns of various lectins to clarify whether or not the binding pattern of Stx1B is just a reflection of general differences in the glycoconjugates depending on the position in the colon. Representative results are shown in Fig. 1, and the data are summarized in Table 2. We examined 10 mice and found no variation from mouse to mouse in the lectin binding patterns in the colon tissue. No other lectins caused such a great difference in the staining patterns between the proximal and distal parts of the colon as that produced by Stx1B, although some differences were observed. GS-I-B4, which recognizes -galactose residues (4), produced strong staining of the apical surface of the proximal colon, while such a position-specific pattern was not seen for other components of the colon. Similarly, PNA, which recognizes the asialo-Galß1-3GalNAc moiety (21), produced intense apical staining of the distal part of the colon, while it stained the crypts of Lieberkühn rather intensely in the proximal colon. LEL, which recognizes the poly-N-acetyllactosamine structure (8), did not stain the epithelium intensely. Two fucose-specific lectins, UEA-I (13, 14) and AAL (26), produced intense staining of the epithelium, especially the crypts of Lieberkühn. However, no difference in binding was observed between the proximal and distal parts of the colon. The lamina propria of the colon was not stained by Stx1B, UEA-I, or AAL. In contrast, GS-I-B4, PNA, and LEL stained the lamina propria rather strongly, and the staining patterns were not different between the proximal and distal parts of the colon. Therefore, the binding pattern of Stx1B, which was highly selective for the epithelium of the distal part of the mouse colon, was unique among those of all lectins tested.

View this table: [in this window] [in a new window]

TABLE 2. Summary of lectin staining of proximal and distal parts of mouse colon

Comparison of carbohydrate binding activity. We examined whether the carbohydrate specificity could be partially common to Stx1B and other lectins. We investigated this by means of a solid-phase binding assay using multivalent ligands tailored for Stx1B. As we have already reported (7), the ligands bound to the immobilized Stx1B (Fig. 2A). An -galactose-specific lectin (GS-I-B4) produced significant binding of the ligands, whereas ß-galactose-reactive lectins (PNA and LEL) did not. A weak interaction with fucose-specific UEA-I was observed, but the level of background binding without the ligands was higher than that produced by other lectins. Similarly, the level of binding of second reagents was too high to evaluate ligand binding to immobilized AAL (data not shown). To confirm the adsorption of lectins, the biotin tags of immobilized lectins were detected (Fig. 2B). The amounts of immobilized lectins, as judged as the binding of HRP-avidin D, were saturated when more than 0.05 µg of lectins was added per well. The results confirmed that sufficient amounts of immobilized lectins were available in the ligand binding experiments when the lectins were immobilized at 0.5 µg per well.

View larger version (17K): [in this window] [in a new window]

FIG. 2. Binding of multivalent carbohydrate ligands to immobilized Stx1B and various lectins. (A) Recombinant Stx1B or various biotin-conjugated lectins were added to wells (0.5 µg per well) to be adsorbed. Various concentrations of the ligands (FITC-Gb3-PLL) (abscissa) were added to the wells, and then ligand binding (ordinate) was assessed with HRP-anti-FITC antibodies. OD 405, optical density at 405 nm. (B) The adsorption of biotin-conjugated lectins to the wells was confirmed. Various amounts (abscissa) of biotinylated lectins were added to the wells to be adsorbed. After unbound lectins had been washed off, the binding of HRP-avidin D (ordinate) was examined to detect adsorbed lectins. In panel B, the baseline signals without lectin adsorption have been subtracted (0.021). Solid circles, Stx1B; open circles, GS-I-B4; solid triangles, UEA-I; open triangles, PNA; open squares, LEL; solid squares, no lectin adsorption. Data are expressed as means ± standard deviations (n = 3).

Restricted expression of glycolipid ligands in the distal colon. To determine whether the selective binding of Stx1B could be due to the differential distribution of glycolipid Gb₃ in the colon, tissue fragments from the proximal (less than 3 cm below) and distal (more than 5 cm below) parts of the colon were separately extracted with chloroform-methanol. After separation on a TLC plate, binding of DIG-Stx1B was examined (Fig. 3). A strong signal reflecting the binding of DIG-Stx1B to the band that exhibited similar mobility to the standard Gb₃ was observed for the sample from the distal part of the colon (lane 9). On the other hand, only a faint band was seen at the corresponding position for the sample from the proximal part of the colon (lane 8). Extracts of kidneys gave a band exhibiting DIG-Stx1B reactivity at the corresponding position (lane 10), but the staining intensity of the band was much weaker than that in the case of the distal colon. Nonspecific adsorption of Stx1B to faster-migrating materials found in both the distal and proximal colon extracts (lanes 8 and 9) was observed. These materials could be neutral lipids or cholesterol under the present TLC conditions. As we have already reported (16), DIG-Stx1B bound to purified Gb₃ (lane 7), but not to purified GalCer (lane 6).

View larger version (82K): [in this window] [in a new window]

FIG. 3. Different Gb3 glycolipid contents in the proximal and distal colon. GalCer (3.3 nmol; lanes 1 and 6), Gb3 (4.6 nmol; lanes 2 and 7), or an extract of the proximal colon (lanes 3 and 8), distal colon (lanes 4 and 9), or kidneys (lanes 5 and 10) was separated on a TLC plate. The amounts of extracts applied were equivalent to tissue dry weights of 0.83, 0.96, and 0.86 mg of the proximal colon, distal colon, and kidneys, respectively. Glycolipids were stained with orcinol-sulfuric acid (lanes 1 to 5) or probed with DIG-Stx1B plus HRP-anti-DIG antibodies (lanes 6 to 10). Glycolipids that bound to DIG-Stx1B with similar mobility to Gb3 (arrows) were abundantly present in the distal colon, but were almost completely absent from the proximal colon. DIG-Stx1B stained purified Gb3 (arrowheads), but not purified GalCer.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Binding sites for Stx1B in the mouse colon were examined by an immunohistochemical approach. The binding sites were restricted to the epithelium of the distal part of the colon. The proximal part of the colon did not show any binding. Because a dramatic transition in the staining pattern was seen in the middle of the colon, the expression of carbohydrate ligands seems to be a reflection of the developmental origin and blood supply: in humans, the proximal part is of midgut origin and is supplied by the superior mesenteric artery, and the distal part is of hindgut origin and is supplied by the inferior mesenteric artery (17).

Although EHEC strains cause hemorrhagic colitis, it is not well known how Stx initially gain access to the bloodstream at an early stage of infection. It has not been determined whether the cytotoxicity of Stx against intestinal epithelial cells could lead to entry of the Stx into the bloodstream due to a breach in the epithelial barrier. On the other hand, in an experiment involving a polarized T84 human cell line, the translocation of Stx (apical to basal) was enhanced when neutrophil transmigration (basal to apical) was induced by chemotactic factors (5). In addition, Stx have been reported to induce the production of interleukin-8 (IL-8) by an Hct-8 colonic carcinoma cell line (24). These studies suggested that neutrophil chemotactic factors (including IL-8) locally available at the sites of infection might induce neutrophil transmigration. The transient reduction in the barrier function of the epithelium caused by the neutrophil transmigration was suggested to be responsible for the passive transfer of Stx into the tissue parenchyma. However, these observations were based on experiments involving cell lines, and the concentration of Stx used to demonstrate translocation was high. Hence, whether passive translocation is the only mechanism responsible for the entry of Stx into the bloodstream remains uncertain.

In clinical situations, studies of the colonic pathology of children who had developed HUS demonstrated that the left and transverse portions of the colon (distal parts of the colon) were the most severely and earliest affected regions of the colon (18). Although one should be cautious about extending speculation about the distribution of Gb₃ in the mouse, it will be interesting to see how Gb₃ might be distributed in the human colon in relation to human diseases.

There are several publications describing a mouse model in which streptomycin-treated mice were orally challenged with EHEC strains (11, 25). The EHEC strains heavily colonized the entire gastrointestinal tract without any pathological changes in colon tissues. Although extensive renal tubular necrosis was observed in moribund mice, no lesions were reported in the colon epithelium. However, more recent studies revealed intestinal hemorrhage and the depletion of goblet cells from the colon tissues in a model of EHEC infection of germfree mice (22).

The differential expression of the binding sites for Stx1B is not trivial, because several control lectins did not produce differential staining of the proximal and distal parts of the colon. Among the control lectins, only GS-I-B4 bound to FITC-Gb₃-PLL, which was designed as a multivalent ligand for Stx1B (7). This ligand consists of a PLL backbone conjugated with globotriose and tagged with FITC. The results are consistent with the facts that GS-I-B4 binds to -galactose residues (4) and globotriose has a terminal -galactose residue. Despite this partial overlap in specificity, GS-I-B4 did not produce a staining pattern restricted to the distal colon. This is probably due to the abundant and rather wide distribution of glycoconjugates with terminal -galactose, which is not necessarily a part of the Gal1-4Gal determinant, in the mouse colon. Two lectins with ß-galactose specificity (PNA and LEL) did not bind to FITC-Gb₃-PLL. They bound with a different pattern to mouse colon. In the case of PNA, the staining of the apical surface was restricted to the distal part of the colon, whereas the cells in the crypts of Lieberkühn were only stained in the proximal part of the colon. UEA-I, one of the lectins commonly used for staining of the intestinal epithelium, has been reported to stain colon M cells and enterocytes from BALB/c mice (3). Consistent with this report, UEA-I bound to the colon epithelium, but no differential staining was observed for the proximal and distal parts. AAL, a lectin related to UEA-I in specificity, also bound to the mouse colon epithelium regardless of the position in the colon. The results indicate that the highly selective expression of the ligands for Stx in the distal part of the colon is unique among those of the lectins examined in the present study.

We next investigated the biochemical basis of the differential expression of the ligands in the epithelium of mouse colon. Extracts from the distal part of the colon contained glycolipids that bound to DIG-Stx1B. These are presumably Gb₃, because they showed mobility similar to that of the standard glycolipid on a TLC plate. On the other hand, the proximal part of the colon was essentially devoid of the corresponding glycolipid ligands. This pattern of the distribution of glycolipid ligands in the mouse colon agrees with that observed with the immunohistochemical approach.

In conclusion, the Stx binding sites in the mouse colon were found to be restricted to the epithelium of the distal part of the colon. The results may suggest that epithelial glycolipid ligands selectively expressed in the distal part of the colon may contribute to the entry of toxins upon EHEC infection. However, one could not exclude the possibility that the avid binding of Stx to the glycolipid ligands may prevent Stx from penetration into underlying tissues or the bloodstream. It would be interesting to see whether Stx could exert selective toxicity against epithelial cells from the distal colon.

 
This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (12033213 and 12680638), TERUMO Life Science Foundation, and the Sankyo Foundation of Life Science, as well as a Goto Research Grant from University of Shizuoka.

We thank Asano Ikegaya, Aya Takatsuki, Takurou Watanabe, Takashi Tanikawa, and Hiroki Nakagami (Department of Microbiology, University of Shizuoka School of Pharmaceutical Sciences) for technical assistance.

 
* Corresponding author. Mailing address: Department of Microbiology, University of Shizuoka School of Pharmaceutical Sciences, 52-1 Yada, Shizuoka-shi, Shizuoka 422-8526, Japan. Phone: 81-54-264-5716. Fax: 81-54-264-5715. E-mail: imai{at}u-shizuoka-ken.ac.jp.

Editor: J. T. Barbieri

Top Abstract Introduction Materials and Methods Results Discussion References

 

1
1. Calderwood, S. B., F. Auclair, A. Donahue-Rolfe, G. T. Keusch, and J. J. Mekalanos. 1987. Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli. Proc. Natl. Acad. Sci. USA 84:4364-4368.[Abstract/Free Full Text]
2
2. Eisenhauer, P. B., P. Chaturvedi, R. E. Fine, A. J. Ritchie, J. S. Pober, T. G. Cleary, and D. S. Newburg. 2001. Tumor necrosis factor alpha increases human cerebral endothelial cell Gb₃ and sensitivity to Shiga toxin. Infect. Immun. 69:1889-1894.[Abstract/Free Full Text]
3
3. Ermak, T. H., and P. J. Giannasca. 1998. Microparticle targeting to M cells. Adv. Drug Delivery Rev. 34:261-283.[CrossRef][Medline]
4
4. Heyes, C. E., and I. J. Goldstein. 1974. An -D-galactosyl-binding lectin from Bandeiraea simplicifolia seeds. Isolation by affinity chromatography and characterization. J. Biol. Chem. 249:1904-1914.[Abstract/Free Full Text]
5
5. Hurley, B. P., C. M. Thorpe, and D. W. K. Acheson. 2001. Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration. Infect. Immun. 69:6148-6155.[Abstract/Free Full Text]
6
6. Imai, Y., T. Fukui, A. Ikegaya, T. Ishikawa, Y. Ono, and K. Kurohane. 2002. Lack of Shiga-like toxin binding sites in germinal centres of mouse lymphoid tissues. Immunology 105:509-514.[CrossRef][Medline]
7
7. Imai, Y., Y. Matsuura, Y. Ono, T. Ishikawa, and Y. Ito. 2001. Demonstration of the pH sensitive binding of multivalent carbohydrate ligands to immobilized Shiga-like toxin 1 B subunits. J. Biochem. (Tokyo) 130:665-670.[Abstract/Free Full Text]
8
8. Kawashima, H., S. Sueyoshi, H. Li, K. Yamamoto, and T. Osawa. 1990. Carbohydrate binding specificities of several poly-N-acetyllactosamine-binding lectins. Glycoconj. J. 7:323-334.[CrossRef][Medline]
9
9. Kita, E., Y. Yunou, T. Kurioka, H. Harada, S. Yoshikawa, K. Mikasa, and N. Higashi. 2000. Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli O157:H7. Infect. Immun. 68:1207-1214.[Abstract/Free Full Text]
10
10. Lindberg, A. A., J. E. Brown, N. Strömberg, M. Westling-Ryd, J. E. Schultz, and K.-A. Karlsson. 1987. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J. Biol. Chem. 262:1779-1785.[Abstract/Free Full Text]
11
11. Lindgren, S. W., A. R. Melton, and A. D. O'Brien. 1993. Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect. Immun. 61:3832-3842.[Abstract/Free Full Text]
12
12. Ling, H., A. Boodhoo, B. Hazes, M. D. Cummings, G. D. Armstrong, J. L. Brunton, and R. J. Read. 1998. Structure of the Shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb₃. Biochemistry 37:1777-1788.[CrossRef][Medline]
13
13. Matsumoto, I., and T. Osawa. 1969. Purification and characterization of an anti-H(O) phytohemagglutinin of Ulex europeus. Biochim. Biophys. Acta 194:180-189.[Medline]
14
14. Matsumoto, I., and T. Osawa. 1971. On the specificity of various heterologous anti-H hemagglutinins. Vox Sang. 21:548-557.[Medline]
15
15. Miyamoto, D., T. Ueno, S. Takashima, K. Ohta, T. Miyawaki, T. Suzuki, and Y. Suzuki. 1997. Establishment of a monoclonal antibody directed against Gb₃Cer/CD77: a useful immunochemical reagent for a differentiation marker in Burkitt's lymphoma and germinal centre B cells. Glycoconj. J. 14:379-388.[CrossRef][Medline]
16
16. Miyashita, S., Y. Matsuura, D. Miyamoto, Y. Suzuki, and Y. Imai. 1999. Development of recombinant B subunit of Shiga-like toxin 1 as a probe to detect carbohydrate ligands in immunochemical and flow cytometric application. Glycoconj. J. 16:697-705.[CrossRef][Medline]
17
17. Moore, K. L., and T. V. N. Persaud. 1998. The developing human: clinical oriented embryology, 6th ed. Saunders, Philadelphia, Pa.
18
18. Murray, K. F., and K. Patterson. 2000. Escherichia coli O157:H7-induced hemolytic-uremic syndrome: histopathologic changes in the colon over time. Pediatr. Dev. Pathol. 3:232-239.[CrossRef][Medline]
19
19. Nataro, J. P., and J. B. Kaper. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201.[Abstract/Free Full Text]
20
20. Sato, K., Y. Imai, and T. Irimura. 1998. Contribution of dermal macrophage trafficking in the sensitization phase of contact hypersensitivity. J. Immunol. 161:6835-6844.[Abstract/Free Full Text]
21
21. Sueyoshi, S., T. Tsuji, and T. Osawa. 1988. Carbohydrate-binding specificities of five lectins that bind to O-glycosyl-linked carbohydrate chains. Quantitative analysis by frontal-affinity chromatography. Carbohydr. Res. 178:213-224.[CrossRef][Medline]
22
22. Taguchi, H., M. Takahashi, H. Yamaguchi, T. Osaki, A. Komatsu, Y. Fujioka, and S. Kamiya. 2002. Experimental infection of germ-free mice with hyper-toxigenic enterohaemorrhagic Escherichia coli O157:H7, strain 6. J. Med. Microbiol. 51:336-343.[Abstract/Free Full Text]
23
23. Takao, T., T. Tanabe, Y.-M. Hong, Y. Shimonishi, H. Kurazono, T. Yutsudo, C. Sasakawa, M. Yoshikawa, and Y. Takeda. 1988. Identity of molecular structure of Shiga-like toxin I (VT1) from Escherichia coli O157:H7 with that of Shiga toxin. Microb. Pathog. 5:357-369.[CrossRef]
24
24. Thorpe, C. M., B. P. Hurley, L. L. Lincicome, M. S. Jacewicz, G. T. Keusch, and D. W. K. Acheson. 1999. Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells. Infect. Immun. 67:5985-5993.[Abstract/Free Full Text]
25
25. Wadolkowski, E. A., J. A. Burris, and A. D. O'Brien. 1990. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect. Immun. 58:2438-2445.[Abstract/Free Full Text]
26
26. Yamashita, K., N. Kochibe, T. Ohkura, I. Ueda, and A. Kobata. 1985. Fractionation of L-fucose-containing oligosaccharides on immobilized Aleuria aurantia lectin. J. Biol. Chem. 260:4688-4693.[Abstract/Free Full Text]

---

Infection and Immunity, February 2003, p. 985-990, Vol. 71, No. 2
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.2.985-990.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Imai, Y. Articles by Miyake, M. Search for Related Content PubMed PubMed Citation Articles by Imai, Y. Articles by Miyake, M.